Company news
BetterLife Pharma Inc. news in 2025
BetterLife Pharma Inc.'s news releases, calls and decks from 2025, newest first.
BetterLife Pharma Announces Engagement with Shanghai-Based YAFO Capital
December 11, 2025
BetterLife Pharma Highlights Advantages of BETR-001 -- a Potent Neuroplastogen
December 4, 2025
BetterLife Pharma Highlights Advantages of BETR-001 - a Potent Neuroplastogen
December 4, 2025
BetterLife Pharma Welcomes Daniel Carcillo as Corporate Advisor
November 25, 2025
BetterLife Pharma Appoints Doug Drysdale as Corporate Advisor
October 22, 2025
USPTO Files ISSUE NOTIFICATION for BetterLife's BETR-001 Composition of Matter Patent
June 18, 2025
BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001
May 28, 2025
BetterLife Provides Comments on CEO’s Share Position Ownership and Recent BCSC Press Release
May 22, 2025
BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders
May 14, 2025
BetterLife Announces Debt Settlements
May 6, 2025
BetterLife Pharma Appoints Corporate Advisor
April 3, 2025
BetterLife Pharma Appoints New Director
March 31, 2025
BetterLife Announces Debt Conversions
March 10, 2025